Comparing the Efficacy of Three Different Nano-scale Bone Substitutes: In vivo Study

Razavi, Sayed Mohammad; Rismanchian, Mansour; Jafari-pozve, Nasim; Nosouhian, Saied

Comparing the Efficacy of Three Different Nano-scale Bone Substitutes: In vivo Study

Document Type : Original Article

Authors

¹ Dental Implants Research Center, Department of Oral Pathology, School of Dentitry, Isfahan University of Medical Sciences, Isfahan, Iran

² Dental Implants Research Center, Department of Prosthodontics, School of Dentitry, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Oral and Maxillofacial Radiology, School of Dentitry, Isfahan University of Medical Sciences, Isfahan; Department of Oral and Maxillofacial Radiology, School of Dentitry, Islamic Azad University, Khorasgan Branch, Isfahan, Iran

Abstract

Background: Synthetic biocompatible bone substitutions have been used widely for bone tissue regeneration as they are safe and effective. The aim of this animal study is to compare the effectiveness of three different biocompatible bone substitutes, including nano-hydroxyapatite (nano-HA) nano-bioglass (nano-BG) and forstrite scaffolds. Materials and Methods: In this interventional and experimental study, four healthy dogs were anesthetized, and the first to fourth premolars were extracted in each quadrant. After healing, the linear incision on the crestal ridge from molar to anterior segment prepared in each quadrant and 16 defects in each dog were prepared. Nano-HA, nano-BG, and forstrite scaffold was prepared according to the size of defects and placed in the 12 defects randomly, four defects remained as a control group. The dogs were sacrificed in four time intervals (15, 30, 45, and 60 days after) and the percentage of different types of regenerated bones (lamellar and woven) and connective tissue were recorded in histological process. The data were analyzed using Mann–Whitney test (α = 0.05). Results: The difference in nano-HA and nano-BG with the control group was significant in three-time intervals regarding the amount of bone formation (P < 0.01). After 15 days, the nano-HA showed the highest amount of woven and lamellar bone regeneration (18.37 ± 1.06 and 30.44 ± 0.54). Conclusion: Nano-HA and nano-BG groups showed a significant amount of bone regeneration, especially after 30 days, but paying more surveys and observation to these materials as bone substitutes seem to be needed.

Keywords

References

1.	El-Gendy R, Yang XB, Newby PJ, Boccaccini AR, Kirkham J. Osteogenic differentiation of human dental pulp stromal cells on 45S5 Bioglass® based scaffolds in vitro and in vivo. Tissue Eng Part A 2013;19:707-15.
2.	Li LJ, Liu N, Shi JG, Liu Q, Jia LS, Yuan W. Osteogenic scaffolds for bone reconstruction. Biores Open Access 2012;1:137-44.
3.	Sàndor GKB, Lindholm TC, Clokie CM. Bone Regeneration of the Craniomaxillofacial and Dento-alveolar Skeletons in the Framework of Tissue Engineering. Finland: University of Oulu; 2003.
4.	Cottrell DA, Wolford LM. Long-term evaluation of the use of coralline hydroxyapatite in orthognathic surgery. J Oral Maxillofac Surg 1998;56:935-41.
5.	Kweon H, Lee KG, Chae CH, Balázsi C, Min SK, Kim JY, et al. Development of nano-hydroxyapatite graft with silk fibroin scaffold as a new bone substitute. J Oral Maxillofac Surg 2011;69:1578-86.
6.	Jones JR, Lin S, Yue S, Lee PD, Hanna JV, Smith ME, et al. Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation. Proc Inst Mech Eng H 2010;224:1373-87.
7.	Välimäki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg 2006;95:95-102.
8.	Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 2002;73:401-8.
9.	Henkel KO, Gerber T, Lenz S, Gundlach KK, Bienengräber V. Macroscopical, histological, and morphometric studies of porous bone-replacement materials in minipigs 8 months after implantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:606-13.
10.	Le Guéhennec L, Layrolle P, Daculsi G. A review of bioceramics and fibrin sealant. Eur Cell Mater 2004;8:1-10.
11.	Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials 2006;27:5014-26.
12.	Williams RL, Brown SA, Merritt K. Electrochemical studies on the influence of proteins on the corrosion of implant alloys. Biomaterials 1988;9:181-6.
13.	Soccol AT, Bettega S, Noronha L, Sass S, Soccol VT, Scholz MR, et al. Defect repair in rat mandible with hydroxyapatite cement compared to small intestine submucosa. Braz J Otorhinolaryngol 2006;72:195-9.
14.	Nandi SK, Kundu B, Ghosh SK, De DK, Basu D. Efficacy of nano-hydroxyapatite prepared by an aqueous solution combustion technique in healing bone defects of goat. J Vet Sci 2008;9:183-91.
15.	Pohunková H, Adam M. Reactivity and the fate of some composite bioimplants based on collagen in connective tissue. Biomaterials 1995;16:67-71.
16.	Strietzel FP, Reichart PA, Graf HL. Lateral alveolar ridge augmentation using a synthetic nano-crystalline hydroxyapatite bone substitution material (Ostim): Preliminary clinical and histological results. Clin Oral Implants Res 2007;18:743-51.
17.	Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999;20:1221-7.
18.	Kim HW, Kim HE, Salih V. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials 2005;26:5221-30.
19.	Saino E, Grandi S, Quartarone E, Maliardi V, Galli D, Bloise N, et al. In vitro calcified matrix deposition by human osteoblasts onto a zinc-containing bioactive glass. Eur Cell Mater 2011;21:59-72.
20.	Brandão SM, Schellini SA, Moraes AD, Padovani CR, Pellizzon CH, Peitl O, et al. Biocompatibility analysis of bioglass® 45S5 and biosilicate® implants in the rabbit eviscerated socket. Orbit 2012;31:143-9.
21.	Chitsazi MT, Shirmohammadi A, Faramarzie M, Pourabbas R, Rostamzadeh AN. A clinical comparison of nano-crystalline hydroxyapatite (Ostim) and autogenous bone graft in the treatment of periodontal intrabony defects. Med Oral Patol Oral Cir Bucal 2011;16:e448-53.
22.	Stavropoulos A, Sima C, Sima A, Nyengaard J, Karring T, Sculean A. Histological evaluation of healing after transalveolar maxillary sinus augmentation with bioglass and autogenous bone. Clin Oral Implants Res 2012;23:125-31.
23.	Gatti AM, Simonetti LA, Monari E, Guidi S, Greenspan D. Bone augmentation with bioactive glass in three cases of dental implant placement. J Biomater Appl 2006;20:325-39.
24.	Fathi MD. Bioactive glass nanopowder and bioglass coating for biocompatibility improvement of metallic implant. J Mater Process Technol 2009;209:1385-91.
25.	Su J, Cao L, Yu B, Song S, Liu X, Wang Z, et al. Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair. Int J Nanomedicine 2012;7:2547-55.
26.	Jones JR. Review of bioactive glass: From Hench to hybrids. Acta Biomater 2013;9:4457-86.
27.	Tavangarian F, Emadi R. Nanostructure effects on the bioactivity of forsterite bioceramic. Mater Lett 2011;65:740-3.
28.	Tavangarian F, Emadi R. Synthesis of nanocrystalline forsterite (Mg₂ SiO₄) powder by combined mechanical activation and thermal treatment. Mater Res Bull 2011;45:388-91.
29.	Diba M, Fathi MH, Kharaziha M. Novel forsterite/polycaprolactone nanocomposite scaffold for tissue engineering applications. Mater Lett 2011;65:1931-4.
30.	Emadi R, Tavangarian F, Roohani Esfahani SI. Biodegradable and bioactive properties of a novel bone scaffold coated with nanocrystalline bioactive glass for bone tissue engineering. Mater Lett 2010;64:1528-31.
31.	Ródenas-Rochina J, Ribelles JL, Lebourg M. Comparative study of PCL-HAp and PCL-bioglass composite scaffolds for bone tissue engineering. J Mater Sci Mater Med 2013;24:1293-308.
32.	Deb S, Mandegaran R, Di Silvio L. A porous scaffold for bone tissue engineering/45S5 Bioglass derived porous scaffolds for co-culturing osteoblasts and endothelial cells. J Mater Sci Mater Med 2010;21:893-905.
33.	Hafezi F, Hosseinnejad F, Fooladi AA, Mafi SM, Amiri A, Nourani MR. Transplantation of nano-bioglass/gelatin scaffold in a non-autogenous setting for bone regeneration in a rabbit ulna. J Mater Sci Mater Med 2012;23:2783-92.
34.	Froum S, Cho SC, Rosenberg E, Rohrer M, Tarnow D. Histological comparison of healing extraction sockets implanted with bioactive glass or demineralized freeze-dried bone allograft: A pilot study. J Periodontol 2002;73:94-102.
35.	Zamet JS, Darbar UR, Griffiths GS, Bulman JS, Brägger U, Bürgin W, et al. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol 1997;24:410-8.
36.	Quinones CL. Utilization of a bioactive synthetic particulate for periodontal therapy and bone augmentation techniques. Pract Periodontics Aesthet Dent 1997;9:1-9.
37.	Tadjoedin ES, de Lange GL, Lyaruu DM, Kuiper L, Burger EH. High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 2002;13:428-36.
38.	Liu Y, Wang G, Cai Y, Ji H, Zhou G, Zhao X, et al. In vitro effects of nanophase hydroxyapatite particles on proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells. J Biomed Mater Res A 2009;90:1083-91.
39.	Huang Y, Zhou G, Zheng L, Liu H, Niu X, Fan Y. Micro-/nano-sized hydroxyapatite directs differentiation of rat bone marrow derived mesenchymal stem cells towards an osteoblast lineage. Nanoscale 2012;4:2484-90.
40.	Götz W, Gerber T, Michel B, Lossdörfer S, Henkel KO, Heinemann F. Immunohistochemical characterization of nanocrystalline hydroxyapatite silica gel (NanoBone (r)) osteogenesis: A study on biopsies from human jaws. Clin Oral Implants Res 2008;19:1016-26.
41.	Schwarz F, Bieling K, Latz T, Nuesry E, Becker J. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series. J Clin Periodontol 2006;33:491-9.
42.	Welch RD, Berry BH, Crawford K, Zhang H, Zobitz M, Bronson D, et al. Subchondral defects in caprine femora augmented with in situ setting hydroxyapatite cement, polymethylmethacrylate, or autogenous bone graft: Biomechanical and histomorphological analysis after two-years. J Orthop Res 2002;20:464-72.
43.	den Boer FC, Wippermann BW, Blokhuis TJ, Patka P, Bakker FC, Haarman HJ. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res 2003;21:521-8.
44.	Kruse A, Jung RE, Nicholls F, Zwahlen RA, Hämmerle CH, Weber FE. Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute material. Clin Oral Implants Res 2011;22:506-11.
45.	Gosain AK; Plastic Surgery Educational Foundation DATA Committee. Bioactive glass for bone replacement in craniomaxillofacial reconstruction. Plast Reconstr Surg 2004;114:590-3.
46.	Azenha MR, Peitl O, Barros VM. Bone response to biosilicates with different crystal phases. Braz Dent J 2010;21:383-9.
47.	Ni S, Chang J.In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics. J Biomater Appl 2009;24:139-58.

Advanced Biomedical Research